Table 3.
First-line treatment modalities†
| Treatment modalities | ||
|---|---|---|
| LS | ES | |
| Cases (%) | Cases (%) | |
| Chemotherapy alone | 30 (23.1) | 127 (77.0) |
| Clinical trials | 0 (0) | 6 (3.6) |
| Combined chemoradiotherapy | 86 (66.2) | 37 (22.4) |
| Sequential chemo-radiation therapy | 34 (26.2) | 25 (15.2) |
| Concurrent chemoradiotherapy | 33 (25.4) | 7 (4.2) |
| Chemo-radio-chemo “sandwich” therapy | 19 (14.6) | 5 (3.0) |
| Surgery alone | 4 (3.1) | 1 (0.6) |
| Surgery with chemotherapy | 6 (4.6) | 0 |
| Surgery with chemoradiotherapy | 3 (2.3) | 0 |
| Radiotherapy alone | 1 (0.7) | 0 |
| Total | 130 | 165 |
†
Staging data was not available for two patients and first-line treatment information was not available for one patient. ES, extensive stage; LS, limited stage.